This question has been answered by the relevant Government Department.
Lord Clement-Jones to ask Her Majesty's Government what incentives, if any, they plan to introduce to ensure that, following Brexit, firms continue to develop intellectual property in the UK, including for paediatric products and orphan medicines; and whether, in so doing, they will take into account any recommendations arising out of the European Commission’s current analysis of intellectual property incentives for the pharmaceutical industry. HL2897
Legend for business item text
† Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Member's Registered Interests
There are no interests to show.